Reaction

Euglycaemic Diabetic Ketoacidosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,934 reports · 60 co-occurring drugs

As of the last recalculation, Euglycaemic Diabetic Ketoacidosis appears in 3,934 FAERS reports alongside 60 co-occurring drug terms. The strongest observed disproportionality signal is EMPAGLIFLOZIN (PRR 330.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Empagliflozin	2,037	330.9	341.2
Dapagliflozin	637	127.7	130.3
Canagliflozin	293	55.9	56.4
Metformin	1,754	46.1	46.3
Metformin Hydrochloride	396	39.3	39.5
Metformin Hydrochloride Tablets	383	39.0	39.3
Metformin Hydrochloride Extended-Release Tablets	383	39.0	39.3
Metformin Hydrochloride Tablet	383	39.0	39.3
Metformin Er 500 Mg	1,378	36.8	36.9
Metformin Er 750 Mg	1,378	36.8	36.9
Insulin Glargine-Yfgn	113	28.1	28.3
Linagliptin	74	21.9	21.9
Sitagliptin	246	19.2	19.3
Insulin Degludec	70	16.0	16.1
Sitagliptin And Metformin Hydrochloride	58	14.4	14.5
Oral Semaglutide	186	14.0	14.1
Indapamide	46	13.7	13.8
Glimepiride	90	12.5	12.5
Dulaglutide	134	8.2	8.3
Insulin	85	8.2	8.2
Liraglutide	75	8.2	8.2
Telmisartan	27	8.1	8.1
Insulin Glulisine	15	7.8	7.8
Fenofibrate	49	7.4	7.4
Pioglitazone	56	6.9	6.9
Sodium Bicarbonate	30	6.9	6.9
Sodium Bicarbonate Injection,	30	6.9	6.9
Rosuvastatin	238	6.5	6.5
Rosuvastatin Calcium	32	6.1	6.1
Dextrose	14	5.6	5.6
Glipizide	64	5.6	5.6
Ceftriaxone Sodium	40	5.6	5.6
Dextrose Monohydrate	14	5.6	5.6
Tenofovir Disoproxil Fumarate Tablets	9	5.5	5.5
Ramipril	124	5.4	5.4
Insulin Glargine	234	5.3	5.3
Ezetimibe	73	5.2	5.2
Clopidogrel Bisulfate	99	5.2	5.2
Ceftriaxone	32	5.2	5.2
Norepinephrine	10	5.0	5.0
Desloratadine	10	4.9	4.9
Amlodipine Besylate And Valsartan	10	4.8	4.8
Bisoprolol Fumarate	120	4.8	4.8
Ritonavir 100 Mg	13	4.6	4.6
Darunavir	13	4.6	4.6
Irbesartan	35	4.2	4.2
Pitavastatin Calcium	8	4.1	4.1
Prochlorperazine Maleate	7	4.0	4.0
Insulin Aspart	48	3.9	3.9
Eplerenone	9	3.7	3.7
Norepinephrine Bitartrate	10	3.7	3.7
Entecavir	8	3.6	3.6
Remdesivir	9	3.6	3.6
Rocuronium Bromide	7	3.1	3.1
Tirzepatide	92	3.1	3.1
Vortioxetine	9	2.8	2.8
Ticagrelor	16	2.7	2.7
Insulin Lispro	62	2.4	2.4
Rifaximin	8	2.0	2.0
Tenofovir Disoproxil Fumarate	11	1.8	1.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.